The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).
about
The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
The clinical impact of Hangesh ...... s (HANGESHA-G and HANGESHA-C).
@en
The clinical impact of Hangeshashinto
@nl
type
label
The clinical impact of Hangesh ...... s (HANGESHA-G and HANGESHA-C).
@en
The clinical impact of Hangeshashinto
@nl
prefLabel
The clinical impact of Hangesh ...... s (HANGESHA-G and HANGESHA-C).
@en
The clinical impact of Hangeshashinto
@nl
P2093
P2860
P356
P1433
P1476
The clinical impact of Hangesh ...... s (HANGESHA-G and HANGESHA-C).
@en
P2093
Akira Tsuburaya
Chu Matsuda
Hideyuki Mishima
Junichi Sakamoto
Kazuaki Tanabe
Kazuhiro Nishikawa
Mari S Oba
Masato Kataoka
Mitsuru Oshiro
Motohiro Imano
P2860
P304
P356
10.7150/JCA.24733
P577
2018-04-19T00:00:00Z